Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ken Griffin Boosts Stake in Affymetrix, Inc. (AFFX); Cuts Penn Virginia Corporation (PVA)

In two new moves filed today with the Securities and Exchange Commission, Ken Griffin and his fund Citadel Investment reported boosting its stake in Vitamin Shoppe Inc (NYSE:VSI) and Affymetrix, Inc. (NASDAQ:AFFX). At the same time, in a third filing, Citadel revealed cutting its position in Penn Virginia Corporation (NYSE:PVA).

CITADEL INVESTMENT GROUP

In Vitamin Shoppe Inc (NYSE:VSI), Citadel revealed ownership of 1.52 million shares, the stake representing 5.0% of the common stock. Earlier, in its latest 13F the fund disclosed holding just around 202,000 shares of the company.

In November, Steven Cohen‘s Sac Capital also surged significantly its position in Vitamin Shoppe Inc (NYSE:VSI), currently owning 1.53 million shares. The stock of Vitamin Shoppe declined by over 20% during the past year, while the average target price is set at $53 per share, well above the current stock price of the company.

In the second filing, Citadel reported raising the stake in Affymetrix, Inc. (NASDAQ:AFFX) to a total of 6.2% of the common stock, the stake amassing 4.75 million shares, well above the previous amount of 38,400 shares held by the fund aside from the shares held under the “Call” and “Put” options. Aside from that, in its latest 13F, Citadel disclosed holding 8.77 million shares in the form of Bonds.

The fund also cut its stake in Penn Virginia Corporation (NYSE:PVA), currently holding 2.96 million shares, versus 4.83 million disclosed earlier. Another notorious investor that is has been bullish on the same stock is George Soros, who in September boosted its position 6.2 million shares, from 1.9 million shares.

Penn Virginia Corporation (NYSE:PVA) is an independent oil and gas company. Its stock surged by over 150% during the past year, trailing a forward P/E of around 57. The mean target price for Penn Virginia Corporation (NYSE:PVA)’s stock is at around $13.9, which is higher than the current price at which the stock trades.

Disclosure: none

Recommended Reading:

Mason Capital Management Boosts Stake in Hubbell Incorporated (HUB.A)

Fisher Asset Management’s Latest Moves Involve Veeco Instruments Inc. (VECO), Wright Medical Group Inc (WMGI), OmniVision Technologies Inc. (OVTI) & Others

Tang Capital Management Is Getting Out of OncoGenex Pharmaceuticals Inc (OGXI) and Cyclacel Pharmaceuticals Inc (CYCC)

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!